State Senator Cordell Cleare, Chair of the Senate Aging Committee, has made research, prevention, and investment in Dementia and Alzheimer’s Care a priority during her entire tenure in the Legislature.
Over 400,000 New Yorkers have Alzheimer’s, the most prevalent form of Dementia, and Black New Yorkers are twice as likely to be diagnosed with dementia, a situation that is exacerbated by longstanding health disparities.
Senator Cleare has repeatedly passed Senate Bill 118, which requires a State-level, centrally located database of successful Dementia and Alzheimer’s disease programs to be made available on the State Office For the Aging (SOFA) website to encourage the sharing of best practices.
She has also advocated for Senate Bill 6509, which would create the Alzheimer’s research Bond Act of 2026 to fund comprehensive research and invest in leading interventions and treatments.
Senator Cleare has been a longstanding supporter of CaringKind, an organization that has been dedicated to specialized care for almost 50 years.
